BH3-only proteins in cell death initiation, malignant disease and anticancer therapy
Open Access
- 28 April 2006
- journal article
- review article
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 13 (8) , 1325-1338
- https://doi.org/10.1038/sj.cdd.4401940
Abstract
No abstract availableKeywords
This publication has 101 references indexed in Scilit:
- Brain ischemia/reperfusion-induced expression of DP5 and its interaction with Bcl-2, thus freeing Bax from Bcl-2/Bax dimmers are mediated by c-Jun N-terminal kinase (JNK) pathwayNeuroscience Letters, 2006
- Evasion of the p53 tumour surveillance network by tumour-derived MYC mutantsNature, 2005
- A Role for Proapoptotic BID in the DNA-Damage ResponseCell, 2005
- Proapoptotic BID Is an ATM Effector in the DNA-Damage ResponseCell, 2005
- Bmf is a possible mediator in histone deacetylase inhibitors FK228 and CBHA-induced apoptosisCell Death & Differentiation, 2005
- Death squads enlisted by the tumour suppressor p53Biochemical and Biophysical Research Communications, 2005
- PUMA expression is significantly reduced in human cutaneous melanomasOncogene, 2004
- Cell Death: Critical Control PointsPublished by Elsevier ,2004
- The Hallmarks of CancerCell, 2000
- The Cell Death-promoting Gene DP5, Which Interacts with the BCL2 Family, Is Induced during Neuronal Apoptosis Following Exposure to Amyloid β ProteinJournal of Biological Chemistry, 1999